BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 11158322)

  • 1. The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors.
    Crawford HC; Fingleton B; Gustavson MD; Kurpios N; Wagenaar RA; Hassell JA; Matrisian LM
    Mol Cell Biol; 2001 Feb; 21(4):1370-83. PubMed ID: 11158322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.
    Crawford HC; Fingleton BM; Rudolph-Owen LA; Goss KJ; Rubinfeld B; Polakis P; Matrisian LM
    Oncogene; 1999 May; 18(18):2883-91. PubMed ID: 10362259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription.
    El-Tanani M; Platt-Higgins A; Rudland PS; Campbell FC
    J Biol Chem; 2004 May; 279(20):20794-806. PubMed ID: 14990565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters.
    Gustavson MD; Crawford HC; Fingleton B; Matrisian LM
    Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic cooperation between the AP-1 and LEF-1 transcription factors in activation of the matrilysin promoter by the src oncogene: implications in cellular invasion.
    Rivat C; Le Floch N; Sabbah M; Teyrol I; Redeuilh G; Bruyneel E; Mareel M; Matrisian LM; Crawford HC; Gespach C; Attoub S
    FASEB J; 2003 Sep; 17(12):1721-3. PubMed ID: 12958188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of monocyte chemotactic protein-3 by activated beta-catenin.
    Fujita M; Furukawa Y; Nagasawa Y; Ogawa M; Nakamura Y
    Cancer Res; 2000 Dec; 60(23):6683-7. PubMed ID: 11118053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors.
    Lynch CC; Crawford HC; Matrisian LM; McDonnell S
    Int J Oncol; 2004 Jun; 24(6):1565-72. PubMed ID: 15138601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
    Tetsu O; McCormick F
    Nature; 1999 Apr; 398(6726):422-6. PubMed ID: 10201372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
    Jung HC; Kim K
    Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-catenin regulates the gene of MMP-26, a novel metalloproteinase expressed both in carcinomas and normal epithelial cells.
    Marchenko ND; Marchenko GN; Weinreb RN; Lindsey JD; Kyshtoobayeva A; Crawford HC; Strongin AY
    Int J Biochem Cell Biol; 2004 May; 36(5):942-56. PubMed ID: 15006646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in responsiveness of human esophageal squamous cell carcinoma lines to epidermal growth factor for MMP-7 expression.
    Xu H; Tanimoto A; Murata Y; Kimura S; Wang KY; Sasaguri Y
    Int J Oncol; 2003 Aug; 23(2):469-76. PubMed ID: 12851697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors.
    Takeda K; Kinoshita I; Shimizu Y; Ohba Y; Itoh T; Matsuno Y; Shichinohe T; Dosaka-Akita H
    BMC Cancer; 2008 Nov; 8():328. PubMed ID: 18992165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PITX2, beta-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter.
    Vadlamudi U; Espinoza HM; Ganga M; Martin DM; Liu X; Engelhardt JF; Amendt BA
    J Cell Sci; 2005 Mar; 118(Pt 6):1129-37. PubMed ID: 15728254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.
    Conacci-Sorrell ME; Ben-Yedidia T; Shtutman M; Feinstein E; Einat P; Ben-Ze'ev A
    Genes Dev; 2002 Aug; 16(16):2058-72. PubMed ID: 12183361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development.
    Nateri AS; Spencer-Dene B; Behrens A
    Nature; 2005 Sep; 437(7056):281-5. PubMed ID: 16007074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The catenin p120ctn inhibits Kaiso-mediated transcriptional repression of the beta-catenin/TCF target gene matrilysin.
    Spring CM; Kelly KF; O'Kelly I; Graham M; Crawford HC; Daniel JM
    Exp Cell Res; 2005 May; 305(2):253-65. PubMed ID: 15817151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.
    Tutter AV; Fryer CJ; Jones KA
    Genes Dev; 2001 Dec; 15(24):3342-54. PubMed ID: 11751639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
    Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H
    Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.
    Naishiro Y; Yamada T; Idogawa M; Honda K; Takada M; Kondo T; Imai K; Hirohashi S
    Oncogene; 2005 Apr; 24(19):3141-53. PubMed ID: 15735679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
    Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
    Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.